Narinder Kumar Mehra is an Indian immunologist, head of the department of transplant immunology and immunogenetics of the SRL Limited, Gurgaon. He is a former dean of research and holds the ICMR Dr. C.G. Pandit National Chair at AIIMS.

• A brief history of the Federation of Immunological Societies of Asia-Oceania (FIMSA) vNarinder K. MehraImmunology and world health: key contributions from the global community 1G. J. V. NossalThe life of regulatory T cells 8Iris K. Gratz, Michael D. Rosenblum, and Abul K. AbbasCross-reactive humoral responses to influenza and their implications for a universal vaccine 13Christopher Chiu, Jens Wrammert, Gui-Mei Li, Megan McCausland, Patrick C. Wilson, and Rafi AhmedThe dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis 22January Weiner 3rd, Jeroen Maertzdorf, and Stefan H. E. KaufmannClinical relevance of antibody development in renal transplantation 30Narinder Mehra, Jamshaid Siddiqui, Ajay Baranwal, Sanjeev Goswami, and Gurvinder KaurTh2-type innate immune responses mediated by natural helper cells 43Shigeo Koyasu and Kazuyo MoroA unique vaccine for control of fertility and therapy of advanced-stage terminal cancers ectopically expressing human chorionic gonadotropin 50G. P. TalwarImmunology of neuromyelitis optica: a T cell-B cell collaboration 57Meike Mitsdoerffer, Vijay Kuchroo, and Thomas KornRegulation of Toll-like receptor signaling pathways in innate immune responses 67Cheng Quian and Xuetao CaoBest Oral Presentation Winners TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes 75Faten El Hage, Aurélie Durgeau, and Fathia Mami-ChouaibProinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes 81Helen E. Thomas, Kate L. Graham, Jonathan Chee, Ranjeny Thomas, Thomas W. Kay, and Balasubramanian KrishnamurthyDevelopment of novel genetic cancer vaccines based on membrane-attached β2 microglobulin 87Gal Cafri, Alon Margalit, Esther Tzehoval, Lea Eisenbach, and Gideon GrossGenomic evaluation of HLA-DR3+ haplotypes associated with type 1 diabetes 91Neeraj Kumar, Gurvinder Kaur, Nikhil Tandon, Uma Kanga, and Narinder MehraPPE2 protein of Mycobacterium tuberculosis may inhibit nitric oxide in activated macrophages 97Khalid Hussain Bhat, Arghya Das, Aparna Srikantam, and Sangita Mukhopadhyay102 Corrigendum for Ann. N.Y. Acad. Sci. 2012.1274: 86-91103 Erratum for Ann. N.Y. Acad. Sci. 2012. 1275: 54-62

Narinder Kumar Mehra is an Indian immunologist, head of the department of transplant immunology and immunogenetics of the SRL Limited, Gurgaon. He is a former dean of research and holds the ICMR Dr. C.G. Pandit National Chair at AIIMS.

• A brief history of the Federation of Immunological Societies of Asia-Oceania (FIMSA) vNarinder K. MehraImmunology and world health: key contributions from the global community 1G. J. V. NossalThe life of regulatory T cells 8Iris K. Gratz, Michael D. Rosenblum, and Abul K. AbbasCross-reactive humoral responses to influenza and their implications for a universal vaccine 13Christopher Chiu, Jens Wrammert, Gui-Mei Li, Megan McCausland, Patrick C. Wilson, and Rafi AhmedThe dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis 22January Weiner 3rd, Jeroen Maertzdorf, and Stefan H. E. KaufmannClinical relevance of antibody development in renal transplantation 30Narinder Mehra, Jamshaid Siddiqui, Ajay Baranwal, Sanjeev Goswami, and Gurvinder KaurTh2-type innate immune responses mediated by natural helper cells 43Shigeo Koyasu and Kazuyo MoroA unique vaccine for control of fertility and therapy of advanced-stage terminal cancers ectopically expressing human chorionic gonadotropin 50G. P. TalwarImmunology of neuromyelitis optica: a T cell-B cell collaboration 57Meike Mitsdoerffer, Vijay Kuchroo, and Thomas KornRegulation of Toll-like receptor signaling pathways in innate immune responses 67Cheng Quian and Xuetao CaoBest Oral Presentation Winners TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes 75Faten El Hage, Aurélie Durgeau, and Fathia Mami-ChouaibProinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes 81Helen E. Thomas, Kate L. Graham, Jonathan Chee, Ranjeny Thomas, Thomas W. Kay, and Balasubramanian KrishnamurthyDevelopment of novel genetic cancer vaccines based on membrane-attached β2 microglobulin 87Gal Cafri, Alon Margalit, Esther Tzehoval, Lea Eisenbach, and Gideon GrossGenomic evaluation of HLA-DR3+ haplotypes associated with type 1 diabetes 91Neeraj Kumar, Gurvinder Kaur, Nikhil Tandon, Uma Kanga, and Narinder MehraPPE2 protein of Mycobacterium tuberculosis may inhibit nitric oxide in activated macrophages 97Khalid Hussain Bhat, Arghya Das, Aparna Srikantam, and Sangita Mukhopadhyay102 Corrigendum for Ann. N.Y. Acad. Sci. 2012.1274: 86-91103 Erratum for Ann. N.Y. Acad. Sci. 2012. 1275: 54-62

Narinder Kumar Mehra is an Indian immunologist, head of the department of transplant immunology and immunogenetics of the SRL Limited, Gurgaon. He is a former dean of research and holds the ICMR Dr. C.G. Pandit National Chair at AIIMS.

• A brief history of the Federation of Immunological Societies of Asia-Oceania (FIMSA) vNarinder K. MehraImmunology and world health: key contributions from the global community 1G. J. V. NossalThe life of regulatory T cells 8Iris K. Gratz, Michael D. Rosenblum, and Abul K. AbbasCross-reactive humoral responses to influenza and their implications for a universal vaccine 13Christopher Chiu, Jens Wrammert, Gui-Mei Li, Megan McCausland, Patrick C. Wilson, and Rafi AhmedThe dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis 22January Weiner 3rd, Jeroen Maertzdorf, and Stefan H. E. KaufmannClinical relevance of antibody development in renal transplantation 30Narinder Mehra, Jamshaid Siddiqui, Ajay Baranwal, Sanjeev Goswami, and Gurvinder KaurTh2-type innate immune responses mediated by natural helper cells 43Shigeo Koyasu and Kazuyo MoroA unique vaccine for control of fertility and therapy of advanced-stage terminal cancers ectopically expressing human chorionic gonadotropin 50G. P. TalwarImmunology of neuromyelitis optica: a T cell-B cell collaboration 57Meike Mitsdoerffer, Vijay Kuchroo, and Thomas KornRegulation of Toll-like receptor signaling pathways in innate immune responses 67Cheng Quian and Xuetao CaoBest Oral Presentation Winners TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes 75Faten El Hage, Aurélie Durgeau, and Fathia Mami-ChouaibProinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes 81Helen E. Thomas, Kate L. Graham, Jonathan Chee, Ranjeny Thomas, Thomas W. Kay, and Balasubramanian KrishnamurthyDevelopment of novel genetic cancer vaccines based on membrane-attached β2 microglobulin 87Gal Cafri, Alon Margalit, Esther Tzehoval, Lea Eisenbach, and Gideon GrossGenomic evaluation of HLA-DR3+ haplotypes associated with type 1 diabetes 91Neeraj Kumar, Gurvinder Kaur, Nikhil Tandon, Uma Kanga, and Narinder MehraPPE2 protein of Mycobacterium tuberculosis may inhibit nitric oxide in activated macrophages 97Khalid Hussain Bhat, Arghya Das, Aparna Srikantam, and Sangita Mukhopadhyay102 Corrigendum for Ann. N.Y. Acad. Sci. 2012.1274: 86-91103 Erratum for Ann. N.Y. Acad. Sci. 2012. 1275: 54-62